Pediatr Blood Cancer
Antibodies, Monoclonal, HumanizedInotuzumab OzogamicinPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Dr. Adonis N. Lorenzana, MD
NPI1902890411PAC ID6406809292
- Publications
- 9
- Clinical trials
- 10
- Industry payments
- $4,708
- Medical groups
- 2
- State license
- 1
- Practice address
- One Hurley Plaza, Flint, MI 48503
- Practice phone
- Call (810) 257-9000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lorenzana's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Adonis N. Lorenzana is a pediatric hematology and oncology physician in Flint, Michigan
Dr. Lorenzana practices at Hurley Medical Center in Flint, Michigan, part of City of Flint, Michigan.
Dr. Lorenzana's NPI, 1902890411, was assigned on September 12, 2005. Dr. Lorenzana holds Michigan license 4301067154.
NPI and contact details
- NPI
- 1902890411NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6406809292
- NPI enumeration date
- September 12, 2005
- NPI status
- Active
- Practice phone
- (810) 257-9000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Adonis N. Lorenzana practices at Hurley Medical Center in Flint, Michigan
Dr. Lorenzana's primary practice is Hurley Medical Center, at One Hurley Plaza, Flint, MI 48503 in Genesee County. The practice phone is (810) 257-9000.
- Hurley Medical CenterOne Hurley Plaza, Flint, MI 48503 · Genesee CountyPhone(810) 257-9000
Source: Dmand AI Affiliation Data
Dr. Adonis N. Lorenzana is affiliated with 2 medical groups
Dr. Lorenzana's primary practice is Hurley Medical Center in Flint, Michigan, part of City of Flint, Michigan. The medical group on file is Hurley Nurse Practitioner Group. Dmand AI also links Dr. Lorenzana to 1 more medical group, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Adonis N. Lorenzana's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lorenzana practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Hurley Medical Center | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Lorenzana practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across City of Flint, Michigan and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Adonis N. Lorenzana is one of 86 pediatric hematologys and oncology physicians in Michigan
Pediatric hematology-oncology is Dr. Lorenzana's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Lorenzana is licensed in Michigan.
Specialties and state licenses
- Pediatric hematology and oncology, MichiganPrimary
Pediatric hematologys and oncology physicians near Dr. Lorenzana
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
86pediatric hematologys and oncology physicians in Michigan
3pediatric hematologys and oncology physicians in Flint
3pediatric hematologys and oncology physicians at Hurley Medical CenterSources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Adonis N. Lorenzana's patients have a median age of 10
Across all payers, Dmand AI patient panel data puts Dr. Lorenzana's median patient age at 10, with 43% women.
Dr. Lorenzana's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 10
Patient panel by sex, all payers
- Women43%
- Men57%
Source: Dmand AI Patient Panel Data
Dr. Adonis N. Lorenzana has 9 publications on record
Dmand AI links 9 papers to Dr. Lorenzana, published from 2013 to 2022. 2017 was the busiest year, with 2. Dr. Lorenzana has published most often in NPJ Precis Oncol. Dr. Lorenzana's most frequent co-authors are Carolyn Bennett, MD, James B. Bussel, MD and Jenny Mcdade Despotovic, DO.
Papers9
Years published2013 to 2022
Dr. Lorenzana's papers by year, 2013 to 2022
Dr. Lorenzana's most frequent co-authors
- Carolyn Bennett, MD2 shared papers
- James B. Bussel, MD2 shared papers
- Jenny Mcdade Despotovic, DO2 shared papers
Recent publications by Dr. Lorenzana
See who Dr. Lorenzana researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lorenzana works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Adonis N. Lorenzana has worked on 10 clinical trials
Dmand AI links Dr. Lorenzana to 10 clinical trials, 8 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Leukemia, Biphenotypic, Acute, Down Syndrome and Fibrolamellar hepatocellular carcinoma. Children's Oncology Group sponsors the most, 7.
Clinical trials with Dr. Lorenzana by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 8Phase 3: 8 trials
- NonePhase 4: no trials
Conditions in Dr. Lorenzana's trials
- Leukemia, Biphenotypic, Acute
- Down Syndrome
- Fibrolamellar hepatocellular carcinoma
- Ganglioneuroblastoma
- Glioblastoma
Investigators on the most trials with Dr. Lorenzana
- Stuart H. Gold, MD8 shared trials
- Jason Law, MD8 shared trials
- Meghann Pine McManus, DO8 shared trials
Recent clinical trials with Dr. Lorenzana
Leukemia, Myeloid, AcuteLeukemia, MyeloidAsparaginase Erwinia chrysanthemiCytarabineDaunorubicin Hydrochloride
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Biphenotypic, AcuteInotuzumab OzogamicinCalaspargase PegolCyclophosphamide
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Hodgkin DiseaseLymphomaBrentuximab VedotinNivolumabDacarbazine
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations (opens in a new tab)
Active, not recruitingPhase 2
GlioblastomaAstrocytomaTemozolomideVeliparibRadiation Therapy
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery (opens in a new tab)
Active, not recruitingPhase 3
Fibrolamellar hepatocellular carcinomaHepatoblastomaCisplatinCarboplatinDoxorubicin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Adonis N. Lorenzana received $4,708 in industry payments from 2016 to 2025
CMS Open Payments shows 159 general payments to Dr. Lorenzana from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,375.
General payments to Dr. Lorenzana by program year, 2016 to 2025
General payments to Dr. Lorenzana by kind, 2016 to 2025
$4.7Kin total
- Food and beverage$2,80660%
- Consulting fees$1,87540%
- Education$271%
Companies that paid Dr. Lorenzana the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Adonis N. Lorenzana's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Adonis N. Lorenzana
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Adonis N. Lorenzana's NPI number?
Dr. Adonis N. Lorenzana's NPI number is 1902890411. It was assigned on September 12, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Adonis N. Lorenzana?
Dr. Adonis N. Lorenzana is a pediatric hematology and oncology physician in Flint, Michigan. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Adonis N. Lorenzana practice?
Dr. Lorenzana practices at One Hurley Plaza, Flint, MI 48503. Dr. Lorenzana's primary practice is Hurley Medical Center in Flint, Michigan, part of City of Flint, Michigan. Dmand AI also links Dr. Lorenzana to 1 medical group.
What is Dr. Adonis N. Lorenzana's office phone number?
The practice phone on file for Dr. Lorenzana is (810) 257-9000.
What is Dr. Adonis N. Lorenzana's medical license number?
Dr. Lorenzana holds Michigan license 4301067154.
Which hospitals is Dr. Adonis N. Lorenzana affiliated with?
Dr. Lorenzana practices at Hurley Medical Center in Flint, Michigan.
What medical group is Dr. Adonis N. Lorenzana part of?
Dr. Lorenzana is linked to Hurley Nurse Practitioner Group. Dmand AI links Dr. Lorenzana to 1 more medical group.
Has Dr. Adonis N. Lorenzana received payments from drug or device companies?
CMS Open Payments shows $4,708 in general payments to Dr. Lorenzana from 43 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Adonis N. Lorenzana been practicing?
Dr. Lorenzana's NPI was assigned in 2005.
Does Dr. Adonis N. Lorenzana do research?
Dmand AI links 9 publications to Dr. Lorenzana, published from 2013 to 2022. Dr. Lorenzana has worked on 10 clinical trials.
Who does Dr. Adonis N. Lorenzana publish with?
Dr. Lorenzana's most frequent co-authors are Carolyn Bennett, MD (2 shared papers), James B. Bussel, MD (2 shared papers) and Jenny Mcdade Despotovic, DO (2 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card